NEW HAVEN, Conn., April 3, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Mary Kay Fenton, Vice President and Chief Financial Officer, will give a corporate presentation at the upcoming Canaccord Adams Hepatitis C Conference on Tuesday, April 7, 2009 at 10:45 a.m. EDT at the Intercontinental Hotel in New York.
